Medications like Ozempic, Wegovy, and Trulicity contain synthetic forms of GLP-1 to support blood sugar management and weight loss, especially for individuals with diabetes
Accessed at www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know
While many people have found success with GLP-1s, others whove taken these diabetes and weight loss medications have experienced severe side effects
Improved kidney function: Recent developments in the management of T2D have identified the use of GLP-1s to reduce the progression of kidney disease in individuals with diabetes
Two main strategies have been used to modify the sequences of semaglutide and tirzepatide (red circles) and increase their bioavailability: 1) removal of the DPP-4 cleavage site, replacing alanine with an analogous molecule (-aminoisobutyric acid (Aib)), but not recognized by the enzyme
Characterizing dual GLP-1/GIP receptor agonists demands tools that resolve receptor engagement with specificity and spatial resolution that conventional approaches cannot provide
